MATTB provides assistance and training through outreach to industry. A: CDER's Division of Drug Information (DDI) serves as a focal point for public inquiries regarding human drug products.

director of the FDA's Center for Drug Evaluation and Research (CDER). "Based on our review of available data, and consistent with the advice of the advisory committee, we are taking this next step ...

One of the most vocal objections came from Dr. Ellis Unger, who was director of the Office of Drug Evaluation at CDER. According to Unger, Woodcock was intensely involved in the review of Exondys ...

M.D., director of the Office of Nonprescription Drug Products in CDER. “Consumers can also talk to their doctor or pharmacist about ways to treat these symptoms.” FDA also stated, "Because a ...

who directs the FDA's Center for Drug Evaluation and Research (CDER), said in the statement. "Based on our review of available data, and consistent with the advice of the advisory committee ...

Dr Patrizia Cavazzoni, director of the FDA’s Center for Drug Evaluation and Research (CDER), said in the agency's notice: 'It is the FDA’s role to ensure that drugs are safe and effective. ' ...

Patrizia Cavazzoni, director of the FDA's Center for Drug Evaluation and Research (CDER), emphasized that the agency's role is to ensure drugs are both safe and effective. She noted that ...

and what specific improvements in speed and accuracy the FDA has observed so far? CDER, in collaboration with the Center for Biologics Evaluation and Research (CBER) and the Center for Devices and ...

The FDA drug shortage program can be contacted for shortage questions via an e-mail account ([email protected]).

During his December 2009 presentation to the FDA–CMS (Centers for Medicare and Medicaid Services) summit, John Jenkins, Director of the Office of New Drugs at CDER, noted that “Incorporating ...